NanoViricides, Inc., a development stage nano-biopharmaceutical company, engages in the discovery, development, and commercialization of anti-viral therapeutics. It has licenses in perpetuity to develop drugs for the treatment of human viral diseases, such as human immunodeficiency virus (HIV/AIDS), Hepatitis B Virus, Hepatitis C Virus (HCV), Herpes Simplex Virus, Rabies, Influenza, and Asian Bird Flu Virus. [...]
Recent Comments